Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction

被引:14
作者
Jover, B
Herizi, A
Mimran, A
机构
[1] Groupe Rein et Hypertension, Centre Hospitalier Universitaire, Montpellier
[2] Groupe Rein et Hypertension, Centre Hospitalier Universitaire, 34 295 Montpellier Cedex 5, Hôpital St Charles
关键词
renal circulation receptors; angiotensin; angiotensin-converting enzyme inhibitors; bradykinin;
D O I
10.1161/01.HYP.27.1.79
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The contribution of endogenous kinins to impairment in renal adaptation to a 6-day period of dietary sodium withdrawal associated with treatment with ramipril (5 mg/kg per day) and losartan (30 mg/kg per day) was evaluated by use of concomitant chronic administration of the bradykinin B-2-receptor antagonist Hoe 140 (150 or 300 mu g/kg per day via subcutaneous osmotic pump). A similar level of higher cumulative sodium excretion was observed in ramipril- and losartan-treated rats compared with untreated animals, and the effect of ramipril was not affected by Hoe 140. Similarly, the fall in arterial pressure and the renal vasodilatation associated with ramipril and losartan were not modified by Hoe 140. Glomerular filtration rate (785+/-73 mu L/min per g KW in untreated sodium-depleted rats) decreased to a larger extent in ramipril-treated rats compared with losartan-treated rats (371+/-78 and 550+/-55 mu L/min per g KW, respectively). Hoe 140 markedly prevented the alteration in glomerular filtration rate associated with ramipril, thus resulting in a final glomerular filtration rate (543+/-41 mu L/min per g KW) similar to that observed with losartan. These findings demonstrate that despite a lack of influence on arterial pressure and sodium balance, accumulation of kinins markedly contributes to deterioration of the glomerular filtration rate induced by ramipril in sodium-depleted rats.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 33 条
[1]  
BAO G, 1992, J CARDIOVASC PHAR S9, V20, P96
[2]   VASODEPRESSOR ROLE OF ENDOGENOUS BRADYKININ ASSESSED BY A BRADYKININ ANTAGONIST [J].
BENETOS, A ;
GAVRAS, H ;
STEWART, JM ;
VAVREK, RJ ;
HATINOGLOU, S ;
GAVRAS, I .
HYPERTENSION, 1986, 8 (11) :971-974
[3]   KININS, NITRIC-OXIDE, AND THE HYPOTENSIVE EFFECT OF CAPTOPRIL AND RAMIPRILAT IN HYPERTENSION [J].
CACHOFEIRO, V ;
SAKAKIBARA, T ;
NASJLETTI, A .
HYPERTENSION, 1992, 19 (02) :138-145
[4]  
CHEN K, 1994, J PHARMACOL EXP THER, V270, P491
[5]  
DOIG JK, 1995, J CARDIOVASC PHARM, V25, P511, DOI 10.1097/00005344-199504000-00001
[6]   HORMONAL MODULATION OF GLOMERULAR FUNCTION [J].
DWORKIN, LD ;
ICHIKAWA, I ;
BRENNER, BM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (02) :F95-F104
[7]   RESPONSE OF ISOLATED RENAL ARTERIOLES TO ACETYLCHOLINE, DOPAMINE, AND BRADYKININ [J].
EDWARDS, RM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (02) :F183-F189
[8]   EFFECT OF AN ANGIOTENSIN-II AND A KININ RECEPTOR ANTAGONIST ON THE RENAL HEMODYNAMIC-RESPONSE TO CAPTOPRIL [J].
FENOY, FJ ;
SCICLI, G ;
CARRETERO, O ;
ROMAN, RJ .
HYPERTENSION, 1991, 17 (06) :1038-1044
[9]   EFFECT OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITION ON BRADYKININ METABOLISM BY VASCULAR ENDOTHELIAL-CELLS [J].
GRAFE, M ;
BOSSALLER, C ;
GRAF, K ;
AUCHSCHWELK, W ;
BAUMGARTEN, CR ;
HILDEBRANDT, A ;
FLECK, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :H1493-H1497
[10]   ACUTE AND CHRONIC ACTIONS OF BRADYKININ ON RENAL-FUNCTION AND ARTERIAL-PRESSURE [J].
GRANGER, JP ;
HALL, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (01) :F87-F92